Skyscape Web Viewer : The Maudsley Prescribing Guidelines in Psychiatry : Main Index

View All
Epilepsy Epilepsy learning difficulties comorbidity psychiatric comorbidities
Equivalent doses and sites of administration for Aristada
Equivalent doses of first-generation antipsychotic medications
Equivalent doses - risperidone-based long-acting injections
Erectile dysfunction
Erythrocyte sedimentation rate, psychotropic agent effects
Escitalopram smokers use in patients with hepatic impairment
Esketamine, enantiomer of ketamine
Esketamine (intranasal)
Espranor ododispersible buprenorphine brand
Established treatments (listed in αbetical order)
estimated glomerular filtration rate (eGFR), renal impairment assessment
Estimated phenotype frequency by ancestry for CYP1A2, CYP2D6, CYP2C19, CYP2C9 and CYP3A4.
Evidence and experience regarding the pharmacological treatment of motor symptoms in Huntington's disease (HD)
Example protocols for transition from low-dose methadone to buprenorphine
Examples of common unlicensed uses of drugs in psychiatric practice
Excited delirium
Excretion of drugs, changes with old age
Excretory capacity of the kidney, estimation in renal impairment assessment
Expectations of treatment, placebo and nocebo effects
extended release (ER) preparations intramuscular injections memantine for older adults
extrapyramidal side effects (EPSEs) amisulpride children features of most common symptoms first generation antipsychotics high-dose antipsychotics methamphetamine use plus antipsychotics patient sensitivity people living with human immunodeficiency virus people with learning difficulties smoking alleviating symptoms switching antipsychotics treatment
Factors affecting adherence
Factors affecting postmortem blood concentrations
Factors associated with antipsychotic-induced pneumonia
Family, improving medication adherence
fasting plasma glucose (FPG) test
Fatal Toxicity Index
Fatal Toxicity Index (FTI), antidepressants
Fatigue multiple sclerosis psychostimulants to reduce in depression